Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 480-450-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2008
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
Study design: in vivo (LLNA)
- Vehicle:
- other: sterile water
- Concentration:
- 10, 25, 50 % (w/w)
- No. of animals per dose:
- 4
Results and discussion
Any other information on results incl. tables
Local irritation :
A discrete erythema was observed at D3 on both ears in one animal, on the left ear or on the right ear
of two other animals and at D6 on the right ear in one animal with test item Sesbania grandiflora dry
purified extract at 50% (w/w) in sterile water.
No increase in cellularity index or in amount of the cells was observed at D6 in comparison with D1.
No significative increase in ear thickness was noted in animals treated with Sesbania 25% and 10%.
In animals treated with Sesbania 50%, a significative increase in ear thickness (+11%) was observed
at D3 that it is related to the slight irritation. At D6, ear thickness was equivalent in comparison with
D1, but the difference was significative in comparison in ear thickness of vehicle which was weaker.
Lymphoproliferative effect:
The test item Sesbania grandiflora dry purified extract, whatever the dose tested, did not produce a
stimulation index equal or greater than 3. Consequently, the EC3 value for the test item Sesbania
grandiflora dry purified extract can not be calculated. Summary results is presented in the following
Table Study results - Sesbania
Groups Treatment/concentrations Viability Amount of cells Cellularity index Stimulation index EC3value Increase in ear thickness
1 Vehicle 77% 2.4 1 1 NA +1%
2 Sesbania - 50% 79% 2.1 0.87 0.9 NA +3%
3 Sesbania - 25% 68% 1.3 0.54 1 NA -4%
4 Sesbania - 10% 70% 1.6 0.68 0.7 NA -2%
5 Acetone 84% 1.4 1 1 NA -9%
6 DNCB - 0.5% 91% 10.5 7.77 5.4 NA +2%
NA = not applicable
Viability = (amount of viable cells / amount of total cells) x 100
Amount of cells (106 cells per node)
Increased in ear thickness (% between day 1 and day 6)
cellularity index = (amount of cells x 106 in the treated group) / (amount of cells x 106 in the vehicle group)
Stimulation index = (mean optical density in the treated group) / ( mean optical density in the vehicle group)
EC3 value = theoretical concentration resulting in a SI value of 3
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Under the experimental conditions adopted, the test item Sesbania grandiflora dry purified extract in sterile water did not induce delayed contact hypersensitivity in the murine Local Lymph Node Assay using CBA female mice after three consecutive days of treatment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.